Table 2

Baseline summary statistics split by trial arm

Trial arm
VariableControl (n=62)CBT (n=65)Total (n=126)
Gender: female, n (%)44 (71)49 (75.4)93 (73.2)
Age (years)58.25 (12.0)61.1 (10.5)59.2 (11.3)
Disease duration (years)14.6 (10.6)14.2 (11.6)14.0 (11.1)
Fatigue measures
 Impact, MAF (0−50)30.5 (9.3)31.0 (9.3)30.7 (9.3)
 Impact, VAS (0–10)5.9 (2.7)6.3 (2.4)6.1 (2.5)
 Severity, VAS (0–10)6.1 (2.5)6.5 (2.3)6.3 (2.4)
 Coping, VAS (0–10)*6.0 (2.3)5.3 (2.4)5.7 (2.4)
Pain, VAS (0–10)4.8 (2.4)4.6 (2.5)4.0 (2.5)
Disease activity, VAS (0–10)4.1 (2.5)3.8 (2.1)4.0 (2.3)
Disability, HAQ (0–10)1.6 (0.7)1.5 (0.6)1.6 (0.7)
Impact disability, PIHAQ (0–9)3.8 (1.9)3.8 (1.7)3.8 (1.8)
Quality of life, RAQoL (0–30)17.6 (6.5)15.6 (6.6)16.6 (6.6)
Anxiety, HADS (0–21)9.1 (4.8)8.3 (4.6)8.7 (4.7)
Depression, HADS (0–21)7.3 (3.9)6.9 (3.4)7.1 (3.7)
Helplessness, AHI (5–30)18.8 (5.0)17.0 (4.6)17.9 (4.8)
Self-efficacy, RASE (28–140)*103.5 (16.5)106.1 (14.1)104.8 (15.3)
Readiness to change, ASOC (8–40)*
 Pre-contemplation18.1 (6.2)18.1 (4.7)18.1 (5.4)
 Contemplation28.9 (6.8)29.0 (5.0)29.0 (6.0)
 Action26.7 (7.1)28.3 (4.3)27.5 (5.8)
 Maintenance25.5 (6.2)25.9 (5.1)25.7 (5.7)
Fatigue change past week, MAF item 16, n (%)
 Decreased3 (4.9)2 (3.1)5 (4.0)
 Same25 (41.0)24 (37.5)49 (39.2)
 Up and down30 (49.2)31 (48.4)61 (48.8)
 Increased3 (4.9)7 (10.9)10 (8)
Sleep quality: good, n (%)27 (45)23 (37.7)50 (41.3)
  • Except where indicated otherwise, all values are expressed as mean (SD). Except where indicated otherwise, high scores reflect worse health.

  • * High scores reflect stronger beliefs.

  • AHI, Arthritis Helplessness Index; ASOC, Arthritis Stages of Change; MAF, Multi-dimensional Assessment of Fatigue (scale); HADS, Hospital Anxiety and Depression Scale; HAQ, Health Assessment Questionnaire; PIHAQ, Personal Impact HAQ; RAQoL, Rheumatoid Arthritis Quality of Life (instrument); RASE, Rheumatoid Arthritis Self-Efficacy scale; VAS, Visual Analogue Scale.